If you think the license is going to be granted. Which there is no logical reason it won't be. Temporary pain. Long-term gain.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025